D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

An immigrant entrepreneur, Andrea Pais cofounded Novel Microdevices by figuring it out as she went along — and learning where to find support.

Local research and biotechnology laboratories Trudeau Institute and Ampersand Biosciences have received a $1 million grant to ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

Story Jan. 22 - Biogen: The neuro-focused biotech is making an undisclosed number of cuts to its research team as it prioritizes its preclinical pipeline and shifts resources to external ...

Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals and said it will be a milestone in the field of biotechnology research. The Genome India ...

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

“I am confident this will be a milestone in the field of biotechnology research,” Prime Minister Modi stated in a video message during the Genomics Data Conclave, organised by the Department ...

China and the U.S. are in a race for preeminence in biotechnology. The U.S. is still dominant in biology and life sciences research, but China is catching up fast. At the same time, Congress and ...

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest funding rounds for a Seattle-area startup in recent years. Tune is using a ...

Each organization is collaborating with nearby research universities to build on biotech research and expansion in their regions. CvilleBioHub, a regional, industry-led organization, received $4.3 ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I'm still ...